About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials in New York | 33 Studies

Clinical Trials MigraineNew York

Migraine Clinical Trials in New York

Find 33 clinical trials for migraine near New York, New York. Connect with research centers in your area.

All Migraine trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-33 of 33 trials

RecruitingA Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of MigraineThis is a long-term safety study to evaluate the safety and tolerability of intermittent use of elismetrep in the acute treatment of migraine attacks.NCT07674654·Birmingham, Alabama and 112 others

Migraine Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedEfficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsThe purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT03732638·Chandler, Arizona and 92 others

CompletedStaccato Prochlorperazine in Migraine (Out Patient)Staccato Prochlorperazine is being developed to treat patients suffering from acute migraine headaches.NCT00422812·Scottsdale, Arizona and 24 others

CompletedSafety and Efficacy Study in Adult Subjects With Acute MigrainesThe purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute MigrainesNCT03235479·Birmingham, Alabama and 49 others

CompletedA Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigraineStudy STS101-007 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101…NCT04940390·Chandler, Arizona and 126 others

CompletedA Study of Home-Delivered Neurostimulation for MigraineThere is a need for better preventive and abortive therapies for migraine.NCT03874351·New York, New York and 1 other

CompletedStudy to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineThis study will evaluate safety and tolerability of treatment with atogepant for the prevention of episodic migraine over the course of one year.NCT03700320·Birmingham, Alabama and 111 others

WithdrawnProtective HA FactorsThis is a naturalistic study of 100 migraineurs and 75 post concussive headache patients who will be asked to record their headaches, medications, sleep and other behaviors in a…NCT02748174·New York, New York

CompletedAn Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackThe purpose of the study is to show the efficacy of a single dose of PRO-513 for treating subjects suffering moderate pain form a migraine attack, with or without aura.NCT00330850·Fairfield, Connecticut and 15 others

CompletedNon-Invasive Neurostimulation For the Relief of Symptoms Associated With MigraineThe purpose of this pilot study is to assess feasibility and clarify the design of future study(ies) to support marketing approval of the GammaCore™ device for the treatment…NCT01532830·San Francisco, California and 2 others

CompletedRandomized Trial in Adult Participants With Acute MigrainesThe purpose of this study is to test the safety and efficacy of BHV-3500 (zavegepant) versus placebo in the acute treatment of moderate or severe migraine.NCT04571060·Huntsville, Alabama and 93 others

CompletedStudy to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineMigraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound.NCT05264129·Birmingham, Alabama and 36 others

TerminatedA Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine PreventionThe purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of…NCT04804033·Phoenix, Arizona and 115 others

PreviousPage 2 of 2

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia